Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moeber Mahzari

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Advances in Therapy|April 8, 2021
Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World SettingMoeber Mahzari, Hawazen Zarif
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 21, 2015
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to ManagementMoeber Mahzari, Amel Arnaout, Mark S Freedman
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|February 1, 2022
Renal Impairment in Patients with Metabolic Syndrome after Living Kidney Donation: A Systematic ReviewFadiyah Abdullah Alajlan, Mohammed Zaid Aljulifi, Moeber Mahzari
Clinical Medicine Insights. Endocrinology and Diabetes|April 11, 2015
Immune checkpoint inhibitor therapy associated hypophysitisMoeber Mahzari, Dora Liu, Amel Arnaout, et al.
Thyroid Research|May 9, 2014
Acute TSH stimulation in vivo does not alter serum PCSK9 levelsAnnemarie Gagnon, Moeber Mahzari, Heather A Lochnan, et al.
Nursing Open|January 20, 2021
A study protocol for a feasibility trial of telephone-delivered Adherence Therapy for adults with type 2 diabetesFatimah Alenazi, Monica Peddle, Daniel Bressington, et al.
Pilot and Feasibility Studies|April 27, 2023
Adherence therapy for adults with type 2 diabetes: a feasibility study of a randomized controlled trialFatimah Alenazi, Monica Peddle, Daniel Bressington, et al.
Clinical Endocrinology|January 6, 2015
Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticlesDylan Burger, AnneMarie Gagnon, Heather A Lochnan, et al.
Advances in Therapy|March 14, 2024
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort AnalysisAwad Alshahrani, Naji Kholaif, Mutaz Al-Khnifsawi, et al.
Advances in Therapy|January 3, 2024
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort AnalysisAwad Alshahrani, Naji Kholaif, Mutaz Al-Khnifsawi, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Advances in Therapy|April 8, 2021
Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World SettingMoeber Mahzari, Hawazen Zarif
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 21, 2015
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to ManagementMoeber Mahzari, Amel Arnaout, Mark S Freedman
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|February 1, 2022
Renal Impairment in Patients with Metabolic Syndrome after Living Kidney Donation: A Systematic ReviewFadiyah Abdullah Alajlan, Mohammed Zaid Aljulifi, Moeber Mahzari
Clinical Medicine Insights. Endocrinology and Diabetes|April 11, 2015
Immune checkpoint inhibitor therapy associated hypophysitisMoeber Mahzari, Dora Liu, Amel Arnaout, et al.
Thyroid Research|May 9, 2014
Acute TSH stimulation in vivo does not alter serum PCSK9 levelsAnnemarie Gagnon, Moeber Mahzari, Heather A Lochnan, et al.
Nursing Open|January 20, 2021
A study protocol for a feasibility trial of telephone-delivered Adherence Therapy for adults with type 2 diabetesFatimah Alenazi, Monica Peddle, Daniel Bressington, et al.
Pilot and Feasibility Studies|April 27, 2023
Adherence therapy for adults with type 2 diabetes: a feasibility study of a randomized controlled trialFatimah Alenazi, Monica Peddle, Daniel Bressington, et al.
Clinical Endocrinology|January 6, 2015
Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticlesDylan Burger, AnneMarie Gagnon, Heather A Lochnan, et al.
Advances in Therapy|March 14, 2024
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort AnalysisAwad Alshahrani, Naji Kholaif, Mutaz Al-Khnifsawi, et al.
Advances in Therapy|January 3, 2024
The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort AnalysisAwad Alshahrani, Naji Kholaif, Mutaz Al-Khnifsawi, et al.
Pageof 3